Ionis Pharmaceuticals (IONS) Stock: Here’s What You Need To Know

Ionis Pharmaceuticals (NASDAQ:IONS) After the market closed on December 23, Ionis had announced that it had received FDA approval, together with Biogen, for its Spinal Muscular Atrophy drug. This drug, known as Spinraza, was developed by both companies to treat patients with Spinal Muscular Atrophy (SMA), a rare-genetic disorder. This was a huge surprise because … Read more